These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 5118286)

  • 21. The place of phenformin in the treatment of diabetes.
    Bloom A
    Postgrad Med J; 1969 May; 45():5-7. PubMed ID: 5364316
    [No Abstract]   [Full Text] [Related]  

  • 22. A dose equivalence study of glybenclamide (daonil)--a new hypoglycaemic agent.
    Mutalik GS; Mitra D; Oak VR; Nayak NJ
    J Assoc Physicians India; 1972 Mar; 20(3):229-34. PubMed ID: 4623893
    [No Abstract]   [Full Text] [Related]  

  • 23. Partial remission of diabetes mellitus after oral antidiabetic therapy.
    Beaser SB; Howard FM
    Postgrad Med; 1971 Mar; 49(3):101-5. PubMed ID: 5547891
    [No Abstract]   [Full Text] [Related]  

  • 24. [Diabetes mellitus. XII. Oral diabetes therapy].
    Bruns W; Michaelis D; Wappler E
    Z Arztl Fortbild (Jena); 1971 Feb; 65(3):125-30. PubMed ID: 5575105
    [No Abstract]   [Full Text] [Related]  

  • 25. [The glibenclamide-phenformin combination in the therapy of diabetes mellitus].
    Polosa P; Mughini L
    Minerva Med; 1974 Aug; 65(59):383-9. PubMed ID: 4213556
    [No Abstract]   [Full Text] [Related]  

  • 26. Intravenous glucose tolerance test following oral tolbutamide administration. A possible model for the evaluation of a new hypoglycaemic agent.
    Gadgil SD; Vaidya AB; Rajagopalan TG; Talwalkar PK; Desai ND; Gupta S; Paul T; Satoskar RS; Bhandarkar SD
    J Postgrad Med; 1983 Apr; 29(2):82-8. PubMed ID: 6631767
    [No Abstract]   [Full Text] [Related]  

  • 27. Glucose tolerance in diabetes mellitus during treatment with the sulfonylurea hypoglycemic agents.
    Herman JB
    Isr J Med Sci; 1966; 2(6):733-7. PubMed ID: 5956689
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical pharmacology of oral antidiabetic agents (second of two parts).
    Shen SW; Bressler R
    N Engl J Med; 1977 Apr; 296(14):787-93. PubMed ID: 320484
    [No Abstract]   [Full Text] [Related]  

  • 29. [Glibenclamide--a better antidiabetic agent?].
    Blohmé G
    Lakartidningen; 1972 Dec; 69(52):6147-9. PubMed ID: 4631025
    [No Abstract]   [Full Text] [Related]  

  • 30. Renal glycosuria treated as diabetes mellitus: case report.
    Orem J; Mpanga L; Habyara E; Nambuya AM; Otim MA
    East Afr Med J; 1997 Nov; 74(11):740-2. PubMed ID: 9557451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glibenclamide therapy in diabetes mellitus.
    Bhattia SK; Hadden DR; Montgomery DA; Weaver JA
    Br Med J; 1970 Jun; 2(5709):570-2. PubMed ID: 5005518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
    Tattersall RB
    Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219
    [No Abstract]   [Full Text] [Related]  

  • 33. [A new hypoglycemic sulfonamide: AN1324].
    Vignalou J; Beck H
    Presse Med (1893); 1968 Oct; 76(38):1827-8. PubMed ID: 5737547
    [No Abstract]   [Full Text] [Related]  

  • 34. [Personal experience on the use of glybenclamide (a new oral hypoglycemic agent)].
    Rodríguez-Miñón JL; Arrieta F; Herrera JL
    Rev Clin Esp; 1970 May; 117(4):371-4. PubMed ID: 5471526
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative effects of acute intravenous loads of tolbutamide, acetohexamide and chlorpropamide in normal and diabetic subjects.
    Wajchenberg BL; Pereira VG; Pupo AA
    Arq Bras Endocrinol Metabol; 1965 Aug; 14(2):143-7. PubMed ID: 5322748
    [No Abstract]   [Full Text] [Related]  

  • 36. An open comparative study of the efficacy and tolerance of a new antidiabetic agent: glipizide.
    De Leeuw I; De Baere H; Decraene P; Lemmens P; Verhaegen H
    Diabetologia; 1973 Sep; ():364-6. PubMed ID: 4204093
    [No Abstract]   [Full Text] [Related]  

  • 37. The treatment of diabetes mellitus with oral hypoglycaemic drugs.
    Duncan LJ; Clarke BF; Munro JF
    Curr Med Drugs; 1965 Jun; 5(10):23-32. PubMed ID: 5878054
    [No Abstract]   [Full Text] [Related]  

  • 38. ORAL HYPOGLYCEMIC DRUGS: COMPARATIVE EVALUATION OF TOLBUTAMIDE, CHLORPROPAMIDE AND PHENFORMIN.
    MOSS JM; DELAWTER DE; GALLAGHER EJ
    Med Times; 1964 Jul; 92():645-54. PubMed ID: 14184191
    [No Abstract]   [Full Text] [Related]  

  • 39. [Chlorpropamide and other oral hypoglycemic agents in the treatment of diabetes mellitus resistant to tolbutamide. Clinico-statistical study].
    Danelon-Martina L
    Clin Ter; 1969 Apr; 49(2):135-46. PubMed ID: 5407314
    [No Abstract]   [Full Text] [Related]  

  • 40. [CONCERNING THE HYPOGLYCEMIC ACTIVITY OF THE ASSOCIATION OF PHENFORMIN AND CHLORPROPAMIDE IN NORMAL SUBJECTS AND IN PATIENTS WITH DIABETES].
    NACCARATO R; SIRIGU F
    Minerva Med; 1963 Aug; 54():2366-71. PubMed ID: 14056606
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.